You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

Litigation Details for ASTRAZENECA AB v. PERRIGO COMPANY PLC (D.N.J. 2015)

✉ Email this page to a colleague

« Back to Dashboard

ASTRAZENECA AB v. PERRIGO COMPANY PLC (D.N.J. 2015)

Docket	⤷ Sign Up	Date Filed	2015-02-04
Court	District Court, D. New Jersey	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Mary Little Cooper
Jury Demand	None	Referred To	Magistrate Judge Tonianne J. B
Patents	6,369,085; 6,428,810; 7,411,070
Link to Docket	External link to docket

Small Molecule Drugs cited in ASTRAZENECA AB v. PERRIGO COMPANY PLC

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Details for ASTRAZENECA AB v. PERRIGO COMPANY PLC (D.N.J. 2015)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2015-02-04	1		The Patents-in-Suit 16. United States Patent No. 6,369,085 (“the ’085 patent”), entitled… sell products covered by United States Patent Nos. 6,369,085 and 7,411,070. 6. On information… This is a civil action for patent infringement arising under the patent laws of the United States, …been and still is the owner of the ’085 patent. The ’085 patent will expire on May 25, 2018, and pediatric… 18. United States Patent No. 7,411,070 (“the ’070 patent”), entitled “Form of S- omeprazole	External link to document
2015-04-22	22		mg and The Patent-in-Suit 22. Plaintiffs admit United States Patent No. 6,369,085 (“the ’085… Plaintiffs admit United States Patent No. 7,411,070 (“the ’070 patent”), entitled “Form of S-Omeprazole…085 patent”), entitled “Form of S-Omeprazole,” was duly and legally issued by the United States Patent…certification with respect to the ’085 and ’070 patents. Plaintiffs deny the remaining allegations of … (Declaration of Non-Infringement of ’085 Patent) 34. Plaintiffs repeat and reassert	External link to document
2015-02-09	4		TRADEMARK NO. OR TRADEMARK 1 US 6,369,085 B1 4/9/2002 … PATENT OR DATE OF PATENT HOLDER OF PATENT OR TRADEMARK…Pleading PATENT OR DATE OF PATENT HOLDER OF PATENT OR TRADEMARK… ____ Trademarks or X Patents. ( ____ the patent action involves 35 U.S.C. § 292.) DOCKET… AO120 Patent/Trademark Form filed. (jjc) (Entered: 02/09/2015) 9 February 2015 PACER Document	External link to document
2015-12-09	53		eight patents listed for NEXIUM 24HR® in the FDA’s Orange Book: U.S. Patent No. 6,369,085 (the “‘…“‘085 patent”) and U.S. Patent No. 7,411,070 (the “‘070 patent”). AstraZeneca did not assert any claims…infringement and invalidity as to U.S. Patent No. 6,428,810 (the “‘810 patent”). [Docket Entry No. 41]. Plaintiffs…Perrigo on the other patents listed in the Orange Book, including the ‘810 patent even though Perrigo…with infringement of the ‘810 patent, then discovery regarding this patent and a Markman hearing will	External link to document
2015-04-01	8		Trademark Office (“USPTO”), U.S. Patent No. 6,369,085 (“the ‘085 patent”) issued on or about April 9, 2002… is required, Defendants admit that U.S. Patent No. 6,369,085 (“the ‘085 …face, the ‘085 patent issued on April 9, 2002. Defendants further admit that the ‘085 patent identifies …required, Defendants admit that U.S. Patent No. 7,411,070 (“the ‘070 patent”) is entitled “Form of S-Omeprazole…, the ‘070 patent issued on August 12, 2008. Defendants further admit that the ‘070 patent identifies	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.